Table 2 Clinical and biochemical characteristics of the study population with differing CAD severity

Sex (M/F)

30/21

92/69(M/F)

46/21(M/F)

180/88(M/F)

Age (years)

67.86 ±1.823

69.97 ±0.8970

68.81 ± 1.438

63.73 ±0.69***

BMI (kg/m²)

22.72 ± 0.2705

23.08 ± 0.1743#

23.78 ± 0.2934#

21.04 ±0.089***

Smokers (%)

15.69

11.18

11.94

5.60*

Hypertension (%)

31.37

21.12

10.35

18.66***

DM (%)

27.45

27.33

20.90

15.30**

AF (%)

13.72

3.73#

1.49#

0***

Stroke (%)

7.84

5.59

10.45

1.12***

High TC (%)

19.61

8.07

8.96

8.21

High TG (%)

17.68

11.80

14.92

7.09*

Low HDL (%)

15.69

30.43

32.84

38.06**

High LDL (%)

13.72

9.32

8.96

9.33

Lp(a) (mg/l)

292.5 ± 33.46

244.4 ± 14.90

295.3 ± 27.06

215.9 ± 11.11**

BUN (mmol/l)

6.424 ± 0.5315

5.628 ± 0.2592

6.147 ± 0.3538

5.075 ± 0.167**

SUA (μmol/l)

364.4 ± 11.62

328.2 ± 8.385#

352.2 ± 11.56#

280.6 ± 6.629***

Glu (mmol/l)

6.555 ± 0.3058

6.658 ± 0.1950

6.281 ± 0.2754

6.011 ± 0.1231*

CHOL (mmol/l)

5.190 ± 0.1761

4.695 ± 0.09342#

4.690 ± 0.1346#

4.821 ± 0.2581

TG (mmol/l)

1.624 ± 0.1808

1.528 ± 0.1039

1.619 ± 0.1391

1.341 ± 0.04895

HDL (mmol/l)

1.322 ± 0.04794

1.240 ± 0.02690

1.246 ± 0.04980

1.242 ±0.02509

LDL (mmol/l)

3.134 ± 0.1226

2.798 ± 0.07992

2.773 ± 0.1157

4.190 ± 1.467

ApoA1 (g/l)

1.449 ± 0.05356

1.308 ± 0.02764#

1.329 ± 0.04026#

1.262 ± 0.02484**

ApoB (g/l)

1.003 ± 0.04239

0.9385 ± 0.0322

0.9414 ± 0.0168

0.8810 ± 0.01690*